Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from NYSE

Eli Lilly Drops CVS Health's Drug Benefit Plan For Employees Ahead Of 2026 Switch

Eli Lilly Co. (NYSE:LLY) is reportedly dropping CVS Health Inc.'s (NYSE:CVS) drug benefit plan for its employees.

Benzinga

Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily'

Dave Ricks, CEO of pharmaceutical giant Eli Lilly and Co. (NYSE:LLY), delivered a scathing critique of pharmacy benefit managers (PBMs), accusing the industry’s “middle actors” of “rent taking” and creating a “terrible incentive” structure that caused insulin list prices to skyrocket.

Benzinga

Google To Run Ohio Data Centers On Solar Power From TotalEnergies

TotalEnergies SE (NYSE:TTE) on Wednesday penned a 15-year Power Purchase Agreement (PPA) with Alphabet Inc.’s (NASDAQ:GOOG) (NASDAQ:GOOGL) Google.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

$5,200 Gold Forecast Puts Mining ETFs On The Hot Seat: Opportunity Or Overreach?

Gold’s rally to record highs may be far from over. With JP Morgan Private Bank forecasting prices could exceed $5,200 per ounce by the end of 2026 and Bank of America calling for $5,000, the yellow metal is again the market’s favorite hedge against fiscal and geopolitical uncertainty. Gold ETFs,…

Benzinga

Getty Images Q3 2025 Earnings Call Transcript

Getty Images Holdings, Inc. (NYSE:GETY) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.

Benzinga

Insurers Slide As Congress Postpones Decision On Health Subsidies, Delays Obamacare Subsidy Vote To December

Shares of major health insurers slid Monday as investors reacted to a Senate deal that ended the 40-day U.S. government shutdown but failed to extend subsidies under the Affordable Care Act (ACA).

Benzinga

GlobalFoundries Secures Next-Gen Chip Tech From Taiwan Semiconductor

GlobalFoundries Inc. (NASDAQ:GFS) announced a technology licensing deal with Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM) to boost the development of advanced Gallium Nitride (GaN) chips for data centers, industrial systems, and electric vehicles.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Organon Cuts 2025 Sales Outlook Despite Earnings Beat

Organon (NYSE:OGN) reported third-quarter adjusted earnings of $1.01 per share on Monday, beating the consensus estimate of 94 cents. The global healthcare company reported quarterly sales of $1.602 billion, beating the Wall Street estimate of $1.56 billion.

Benzinga

Eli Lilly Expands Genetic Eye-Disease Focused Pipeline With MeiraGTx Gene Therapy Collaboration

MeiraGTx Holdings plc (NASDAQ:MGTX) stock is trading higher after the company inked a strategic collaboration in the area of ophthalmology with Eli Lilly and Co. (NYSE:LLY).

Benzinga

Top Stocks With Earnings This Week: Plug, Oklo, Circle And More

The pace of earnings season slows down in the days ahead, but there are still plenty of retail-favorite names set to report this week.

Benzinga

Markets Turn Bullish as Senate Strikes Deal to End Record US Shutdown

Shares rose as the US Senate reached a new deal to end the longest government shutdown in the nation's history.

International Business Times UK

Consumer Tech News (Nov 3-7): Trump Blocks Nvidia Blackwell AI Chip Exports, China Bans Foreign AI Chips In Data Centers & More

President Donald Trump has declared that Nvidia's (NASDAQ:NVDA) advanced Blackwell AI chip will not be available for "other people." This decision comes amid concerns about the potential sale of a scaled-down version to China.

Benzinga

Visa, Mastercard Near Historic Settlement With Merchants: Could Cut Fees, Let Stores Reject Rewards Cards

Visa Inc. (NYSE:V) and Mastercard Inc. (NYSE:MA) are reportedly close to settling with merchants that could reduce credit card fees and give retailers more flexibility in deciding which cards to accept.

Benzinga

MSTR Falls To $230 Despite Strategy's Upsized Stock Offering

Strategy Inc. (NASDAQ:MSTR) announced an increase of a high-yield preferred offering to fund more Bitcoin (CRYPTO: BTC) purchases, but MSTR shares plunged to $230 as traders sold the news.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Jamie Dimon Refuses To Join Big Tech Donors Like Google, Apple, Amazon Funding Trump's $300 Million White House Ballroom: 'We Have An Issue...'

JPMorgan Chase (NYSE:JPM) CEO Jamie Dimon has made it clear that his bank will not contribute to the Donald Trump administration's $300 million White House ballroom project — even as some of the biggest names in tech and business open their checkbooks.

Benzinga

NRG Energy Tops Q3 Earnings, $3B Share Repurchase Program Extends Through 2028

NRG Energy, Inc.'s (NYSE:NRG) shares are declining on Thursday after the company reported third-quarter 2025 results.

Benzinga

This Industrial Giant Stock Hit 52-Week High On Strong Aerospace Performance

Parker Hannifin Corp. (NYSE:PH) stock is trading higher on Thursday after it reported first-quarter FY26 sales of record $5.08 billion, exceeding analyst expectations of $4.94 billion.

Benzinga

DuPont Trims Outlook After Qnity Spinoff And Aramids Sale

DuPont de Nemours, Inc. (NYSE:DD) shares were volatile Thursday after the company reported third-quarter 2025 results that exceeded Wall Street expectations but reduced its full-year outlook.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday?

Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid solid corporate earnings and growing signs that the Federal Reserve may be nearing another interest rate cut.

Barchart

Market Downturn Offers New Opportunities: Two 52-Week Low Stocks Worth a Bet

For the first time in weeks, there were more new 52-week lows than 52-week highs yesterday. That will happen when stocks course correct on valuation concerns. This market downturn spells opportunity. Here are two new 52-week lows worth a bet.

Benzinga

Humana Q3 Premium Growth Offsets Membership Drop, Stock Tumbles

Humana Inc. (NYSE:HUM) released its third-quarter earnings report on Wednesday, with adjusted earnings of $3.24, exceeding the consensus estimate of $2.82.

Benzinga

Owens Corning Navigates Easing Tariffs, Battles Housing Market Headwinds

Owens Corning (NYSE:OC) shares fell premarket on Wednesday after the company reported third-quarter 2025 results that missed analyst expectations on both earnings and revenue.

Benzinga

Grab To Launch Autonomous Robobuses In Singapore In 2026, Retrain Drivers For New Tech Roles: 'We See New Kinds Of Jobs Emerging'

Grab Holdings Limited (NASDAQ:GRAB) plans to introduce autonomous robobuses in Singapore in early 2026, while exploring ways to retrain human drivers for emerging technology-focused roles.

International Business Times UK

Big Short Legend Michael Burry Doubles Lululemon Stake and Buys Three New Stocks in Bold Q3 Moves

Michael Burry boosted his positions in apparel, healthcare, and scientific stocks, while trimming major holdings, showing a cautious yet opportunistic stance in Q3.

Benzinga

Palantir Weighs On Wall Street, Bitcoin Slumps 5%: What's Moving Markets Tuesday?

Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, offering a convenient excuse to take profits after strong year-to-date rallies.

1 … 35 36 37 38

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.